ANNUAL RATE OF FVC DECLINE IN VARIOUS PATIENT SUB-GROUPS WITH IDIOPATHIC PULMONARY FIBROSIS TREATED WITH PIRFENIDONE: POOLED ANALYSIS FROM 3 PIVOTAL STUDIES

Noble P. W.; Albera C.; Chou W.; Costabel U.; Day B.; Glaspole I.; Glassberg M. K.; Lancaster L.; Lederer D. J.; Nathan S. D.; Pereira C. A.; Stauffer J.; Swigris J. J.

首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >ANNUAL RATE OF FVC DECLINE IN VARIOUS PATIENT SUB-GROUPS WITH IDIOPATHIC PULMONARY FIBROSIS TREATED WITH PIRFENIDONE: POOLED ANALYSIS FROM 3 PIVOTAL STUDIES

【24h】

ANNUAL RATE OF FVC DECLINE IN VARIOUS PATIENT SUB-GROUPS WITH IDIOPATHIC PULMONARY FIBROSIS TREATED WITH PIRFENIDONE: POOLED ANALYSIS FROM 3 PIVOTAL STUDIES

机译：吡非尼酮治疗的特发性肺纤维化患者亚组中FVC的年率下降：3项重要研究的结果分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Thorax: The Journal of the British Thoracic Society》 |2016年第3期|共1页
作者
Noble P. W.; Albera C.; Chou W.; Costabel U.; Day B.; Glaspole I.; Glassberg M. K.; Lancaster L.; Lederer D. J.; Nathan S. D.; Pereira C. A.; Stauffer J.; Swigris J. J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. ANNUAL RATE OF FVC DECLINE IN VARIOUS PATIENT SUB-GROUPS WITH IDIOPATHIC PULMONARY FIBROSIS TREATED WITH PIRFENIDONE: POOLED ANALYSIS FROM 3 PIVOTAL STUDIES [J] . Noble P. W., Albera C., Chou W., Thorax: The Journal of the British Thoracic Society . 2016,第Suppla3期

机译：吡非尼酮治疗的特发性肺纤维化患者亚组中FVC的年率下降：3项重要研究的结果分析
2. EFFECT OF PIRFENIDONE ON ALL-CAUSE MORTALITY (ACM) AND FORCED VITAL CAPACITY (FVC) IN IDIOPATHIC PULMONARY FIBROSIS (IPF) PATIENTS WITH LOW FVC AND/OR LOW DLCO: ANALYSIS OF POOLED DATA FROM ASCEND AND CAPACITY [J] . Nathan S. D., Costabel U., Albera C., Thorax: The Journal of the British Thoracic Society . 2017,第Suppla3期

机译：Pirefenidone对特发性肺纤维化（IPF）低FVC和/或低DLCO患者的所有原因死亡率（ACM）和强制生命能力（FVC）的影响：从升高和容量分析汇总数据
3. ANNUAL RATE OF FVC DECLINE IN PATIENTS WITH IPF TREATED WITH PIRFENIDONE: POOLED ANALYSIS (ENCORE) [J] . Noble Paul W., Albera Carlo, Chou Willis, Respirology : . 2017,第Suppla2期

机译：用Pirefenidone治疗IPF患者的FVC患者的年度率：汇总分析（ENCORE）
4. Acoustic evaluation of pirfenidone on patients with combined pulmonary fibrosis emphysema syndrome [C] . Sonia Charleston-Villalobos, Norma Castañeda-Villa, Ramón Gonzàlez-Camarena, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：吡非尼酮对合并肺纤维化性肺气肿综合征的声学评价
5. Correlation of Vascular Leak Measured Using Gadofosveset-Enhanced Lung Magnetic Resonance Imaging with Radiographic and Physiologic Measures of Fibrosis in Patients with Idiopathic Pulmonary Fibrosis. [D] . Liang, Lloyd. 2018

机译：特发性肺纤维化患者使用Gadofosveset增强肺磁共振成像测得的血管渗漏与纤维化的放射学和生理学指标的相关性。
6. Original article: Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis [O] . Steven D Nathan, Carlo Albera, Williamson Z Bradford, -1

机译：原始文章：强制性肺活量的临床意义下降后继续用吡非尼酮治疗的效果：特发性肺纤维化患者三项三期试验的数据分析
7. S97 Annual rate of fvc decline in various patient sub-groups with idiopathic pulmonary fibrosis treated with pirfenidone: pooled analysis from 3 pivotal studies [O] . PW Noble, C Albera, W Chou, 2016

机译：S97患有分性肺纤维化的各种患者小组的每年FVC下降率，Pirfenidone治疗：3个关键研究的合并分析

ANNUAL RATE OF FVC DECLINE IN VARIOUS PATIENT SUB-GROUPS WITH IDIOPATHIC PULMONARY FIBROSIS TREATED WITH PIRFENIDONE: POOLED ANALYSIS FROM 3 PIVOTAL STUDIES

著录项

引文网络

相似文献

相关主题

期刊订阅